Select Publications
Journal articles
2005, 'A multi-institutional study of extracorporeal photoimmune therapy (ECP) with UVADEX (R) for the prevention of acute gvhd in patients (PTS) undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation (AHCT)', Biology of Blood and Marrow Transplantation, 11, pp. 37 - 37
,2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, 106, pp. 389B - 389B
,2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B
,2005, 'Extracorporeal photoimmune therapy with UVADEX for the prevention of acute graft-versus-host disease in patients undergoing standard myeloablative conditioning and allogeneic haematopoetic stem cell transplantation', Bone Marrow Transplantation, 35, pp. S132 - S132
,2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B
,2005, 'Haemopoietic stem cell transplanation in Australia and New Zealand, 1992-2001:Progress report from the Australasian Bone Marrow Transplant Recipient Registry', Internal Medicine Journal, 35, pp. 18 - 27
,2005, 'Haemopoietic stem cell transplantation in Australia and New Zealand,1992-2001: progress report from the Australasian Bone Marrow TransplantRecipient Registry', Internal Medicine Journal, 35, pp. 18 - 27
,2004, 'A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.', Blood, 104, pp. 1230 - 1230, http://dx.doi.org/10.1182/blood.v104.11.1230.1230
,2004, 'Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: A phase III study', Leukemia, 18, pp. 309 - 315, http://dx.doi.org/10.1038/sj.leu.2403217
,2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B
,2004, 'A multi-institutional study of extracorporeal photoimmune therapy with UVADEX (R) for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation', Blood, 104, pp. 347A - 347A
,2004, 'A multi-institutional study of extracorporeal photophoresis (ECP) withUvadex (R) for the prevention of acute graft vs. host disease (aGvHD)in patients (pts) undergoing allogeneic hematopoietic progenitor celltransplants (allo-HPCT) with myeloablative', Biology of Blood and Marrow Transplantation, 10, pp. 53 - 53
,2004, 'Reduced-intensity allogeneic transplants: an update report from theAustralasian Bone Marrow Transplant Recipient Registry', Bone Marrow Transplantation, 33, pp. S104 - S104
,2003, '79 Stem cell transplantation in Australia and New Zealand: An update from the Australasian bone marrow transplant recipient registry (ABMTRR)', Biology of Blood and Marrow Transplantation, 9, pp. 88 - 88, http://dx.doi.org/10.1016/s1083-8791(03)80080-0
,2003, 'Extracorporeal photoimmune therapy with Uvadex (R) for the preventionof acute graft versus host disease in patients undergoing standardmyeloablative conditioning and allogeneic hematopoietic stem celltransplantation', Blood, 102, pp. 714A - 714A
,2003, 'Posterior Leukoencephalopathy in Association with the Tumour Lysis Syndrome in Acute Lymphoblastic Leukaemia - A case with Clinicopathological Correlation', Leukemia and Lymphoma, 44, pp. 719 - 721
,2001, 'Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow', Bone Marrow Transplantation, 28, pp. 21 - 27, http://dx.doi.org/10.1038/sj.bmt.1703088
,2001, 'Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia', British Journal of Haematology, 113, pp. 727 - 736
,2001, 'Peripheral blood stem cells: Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow.', Bone Marrow Transplantation, pp. 21 - 27
,2001, 'Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bcl 2-IgH rearrangements, without expression of either activated oncogene', Leukemia Research, pp. 359 - 360
,2001, 'Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bel 2-IgH rearrangements, without expression of either activated oncogene.', Leukemia Research, pp. 359 - 360
,2000, 'Second allogenic transplant for leukaemia after failed first autologous transplant', Blood, 96
,2000, 'Allogeneic PBPC transplantation: An effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?', Bone Marrow Transplantation, 25, pp. 119 - 120, http://dx.doi.org/10.1038/sj.bmt.1702090
,1999, 'Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia', British Journal of Haematology, 107, pp. 409 - 418
,1999, 'Haemorrhagic Cystitis: incidence and risk factors in a transplant population using hyperhydration', Bone Marrow Transplantation, pp. 797 - 801
,1998, 'A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989', Bone Marrow Transplantation, pp. 691 - 695
,1998, 'A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989.', Bone Marrow Transplantation, pp. 691 - 695
,1997, 'Haemorrhagic cystitis - A manifestation of graft-versushost disease?', Experimental Hematology, 25, pp. 823
,1997, 'Reduced morbidity and mortality in autologous bone marrow transplantation: The role of prophylactic fluconazole, norfloxacin and heparin.', BLOOD, 90, pp. 4430 - 4430, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YG42501739&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Haemorrhagic cystitis - A manifestation of graft-versus-host disease?', EXPERIMENTAL HEMATOLOGY, 25, pp. 329 - 329, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XR33000319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x
,1996, 'A safety study of Albumex 5, a human albumin solution plroduced byion exchange chromatography', Vox Sanguinis, pp. 198 - 202
,1996, 'A Safety Study of Albumex® 5, a Human Albumin Solution Produced by Ion Exchange Chromatography', Vox Sanguinis, 70, pp. 198 - 202, http://dx.doi.org/10.1159/000462115
,1996, 'Five year leukaemia free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation', Australian and New Zealand Journal of Medicine, pp. 54 - 58
,1995, 'REDUCED MORBIDITY AND MORTALITY ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPROVED RESULTS WITH FLUCONAZOLE, NORFLOXACIN AND HEPARIN', EXPERIMENTAL HEMATOLOGY, 23, pp. 857 - 857, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RP11600398&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1995, 'A prospective randomised double blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA identical sibling donors', Bone Marrow Transplantation, 15, pp. 129 - 134
,1995, 'Autologus blood stem cell transplantation for haematological malignancy: treatment-related mortality of 2%', Australian and New Zealand Journal of Medicine, pp. 483 - 489
,1995, 'Expression of cytokine genes in T cell leukaemias', Pathology, pp. 347 - 351
,1994, 'Lack of efficacy of a short ex vivo incubation of human allogeneic donor marrow with recombinant human GM-CSF prior to its infusion into the recipient', Bone Marrow Transplantation, 14, pp. 573 - 577
,1994, 'PROGNOSTIC VALUE OF IMMUNOPHENOTYPING IN ACUTE MYELOID-LEUKEMIA', BLOOD, 84, pp. 1220 - 1225, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PC40200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1994, 'The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia', Leukemia and Lymphoma, 15, pp. 79 - 84, http://dx.doi.org/10.3109/10428199409051681
,1993, 'Changing results of HLA‐identical sibling bone marrow transplantation in patients with haematological malignancy during the period 1981–1990', Australian and New Zealand Journal of Medicine, 23, pp. 181 - 186, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01814.x
,1993, 'Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): An update', Seminars in Oncology, 20, pp. 27 - 31
,1993, 'Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney', Australian and New Zealand Journal of Medicine, 23, pp. 450 - 457, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01829.x
,1992, 'Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2', Blood, 80, pp. 1352 - 1357
,1992, 'Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2', Blood, 80, pp. 1352 - 1357, http://dx.doi.org/10.1182/blood.v80.5.1352.bloodjournal8051352
,1992, 'EXVIVO INCUBATION OF HUMAN ALLOGENEIC DONOR MARROW WITH RECOMBINANT HUMAN GM-CSF PRIOR TO ITS INFUSION INTO THE RECIPIENT', EXPERIMENTAL HEMATOLOGY, 20, pp. 770 - 770, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JA73400251&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1992, 'High dose chemotherapy and autologous bone marrow transplantation in advanced Hodgkin's disease', Medical Journal of Australia, 157, pp. 527 - 530, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137348.x
,1991, 'ERADICATION OF CLINICAL CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH THE USE OF PROPHYLACTIC GANCICLOVIR', EXPERIMENTAL HEMATOLOGY, 19, pp. 578 - 578, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FQ31000456&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1991, 'IMPROVING RESULTS OF HLA-IDENTICAL SIBLING MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990', EXPERIMENTAL HEMATOLOGY, 19, pp. 578 - 578, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FQ31000457&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,